Hepatitis C Stocks

Description:

This portfolio consists of public companies that are researching a cure for Hepatitis C which affects 170 million people worldwide

"The hottest area in drug development right now and for the next couple of years is hepatitis C," said Kris Jenner, whow runs the $1.7 billion T. Rowe Price Health Sciences Fund.
Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

3 Tech Stocks Under $10 Triggering Breakout Trades

09.19.14 | 08:21 AM

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percen...

Dividend Preview: 5 Dividend Stocks Ready to Pay You More

09.19.14 | 09:07 AM

BALTIMORE (Stockpickr) -- Don't get fooled by the flash of new all-time highs in the big stock indices; if you're not buying dividend names, you're...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter